MONOFERRIC

Drug Pharmacosmos Therapeutics Inc.
Total Payments
$3.3M
Transactions
12,863
Doctors
6,252
Companies
1

Payment Trends by Year

Year Amount Transactions Doctors
2024 $1.4M 4,806 3,043
2023 $1.1M 4,934 2,932
2022 $762,878 3,123 1,875

Payments by Nature

Nature of Payment Amount Transactions Share
Honoraria $1.3M 431 40.2%
Travel and Lodging $820,268 1,100 25.2%
Consulting Fee $745,379 103 22.9%
Food and Beverage $377,662 11,213 11.6%
Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $4,613 7 0.1%
Education $321.39 9 0.0%

Top Doctors Receiving Payments for MONOFERRIC — Page 4

Doctor Specialty Location Total Records
, MD Hematology & Oncology Philadelphia, PA $6,269 4
, MD Internal Medicine Boston, MA $6,200 5
, MD Blood Banking & Transfusion Medicine Saint Louis, MO $6,168 3
, MD Medical Oncology Chicago, IL $6,042 12
, D.O Anesthesiology Parsippany, NJ $5,717 3
, MD Internal Medicine Dyer, IN $5,677 15
, MD Hematology & Oncology Jefferson City, MO $5,617 14
, MD Hematology & Oncology Dearborn, MI $5,510 18
, MD Hematology & Oncology Lubbock, TX $5,372 7
, MD Hematology & Oncology Morristown, NJ $5,345 14
, M.D Hematology & Oncology Tamarac, FL $5,332 22
, M.D Gastroenterology Providence, RI $5,300 10
, M.D Thoracic Surgery (Cardiothoracic Vascular Surgery) Springfield, MA $5,203 3
, M. D Medical Oncology Cleveland, OH $5,179 11
Kaci Weaver Acute Care Birmingham, AL $5,170 17
, MD Cardiovascular Disease New York, NY $5,102 10
, MD Hematology & Oncology Federal Way, WA $4,948 12
, M.D Hematology & Oncology Downey, CA $4,788 9
, MD Hematology & Oncology Pikeville, KY $4,721 13
, M.D Hematology & Oncology New York, NY $4,634 8
, MD Medical Oncology Irving, TX $4,618 5
, MD Hematology & Oncology Summit, NJ $4,577 11
, D.D.S.,M.S Orthodontics and Dentofacial Orthopedics Evanston, IL $4,336 1
, MD Anesthesiology Boston, MA $4,292 5
, MD, MPH Cardiovascular Disease Philadelphia, PA $4,253 2

About MONOFERRIC

MONOFERRIC is a drug associated with $3.3M in payments to 6,252 healthcare providers, recorded across 12,863 transactions in the CMS Open Payments database. The primary manufacturer is Pharmacosmos Therapeutics Inc..

Payment data is available from 2022 to 2024. In 2024, $1.4M was paid across 4,806 transactions to 3,043 doctors.

The most common payment nature for MONOFERRIC is "Honoraria" ($1.3M, 40.2% of total).